Dr. Scot Gottlieb on Novo Nodrisk’s oral diabetes drug, future of weight-loss drugs

Former FDA Commissioner Dr. Scot Gottlieb joins ‘Squawk Box’ to discuss news of Novo Nordisk’s oral diabetes drug cutting heart-related risks in patients, state of the weight-loss drugs market, and more.